SMTL ID : 3heg.1

P38 in complex with Sorafenib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x BAX: 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE(Non-covalent)

BAX.1: 20 residues within 4Å: Chain A: V.26, V.34, A.47, K.49, E.67, L.70, L.71, M.74, V.79, I.80, T.102, H.103, M.105, I.137, I.142, H.144, I.162, L.163, D.164, F.165 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.34, A:A.47, A:K.49, A:L.70, A:L.70, A:L.71, A:I.80, A:I.80, A:T.102, A:D.164 Hydrogen bonds: A:E.67, A:E.67, A:M.105, A:D.164 Halogen bonds: A:I.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Namboodiri, H.V. et al., Analysis of imatinib and sorafenib binding to p38alpha compared with c-Abl and b-Raf provides structural insights for understanding the selectivity of inhibitors targeting the DFG-out form of protein kinases. Biochemistry (2010)

Release Date

2009-11-10

Peptides

Mitogen-activated protein kinase 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 14

Related Entries With Identical Sequence